期刊
FRONTIERS IN ONCOLOGY
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2019.00602
关键词
Withania somnifera; folic acid; i-Extract; nanomedicine; chemotherapy
类别
资金
- Japan Society for the Promotion of Science (JSPS) KAKENHI [16H03834, 19H00857]
- JSPS KAKENHI [16K13632]
- JSPS KAKENHI Fund for the Promotion of Joint International Research (Fostering Joint International Research) [16KK0117]
- DBT (Government of India)
- AIST (Japan)
- Grants-in-Aid for Scientific Research [16K13632, 19H00857] Funding Source: KAKEN
Nanomedicine holds great potential for drug delivery to achieve more effective and safer cancer treatment. Earlier, we reported that the alcoholic extract of Withania somnifera leaves (i-Extract) has selective cancer cell killing activity. Herein, we developed a folate receptor-targeting i-Extract nanocomplex (FRi-ExNC) that suspends well in water and possesses enhanced selective anticancer activity in both in vitro and in vivo assays. Comparative analyses of folate receptor (FR)-positive and -negative cells revealed that FRi-ExNC caused a stronger decrease in Cyclin D/Cdk4 and anti-apoptotic protein Bcl-2, as well as a higher increase in the growth arrest regulating protein p21(WAF)(1 )and pro-apoptotic protein PARP-1, in FR-enriched cancer cells. Our results demonstrate that FRi-ExNC could be a natural source-based nanomedicine for targeted cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据